Search | IOVS | ARVO Journals

Showing 1 – 20 of 21

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

The prognostic power of baseline visual function deficits in intermediate age-related macular degeneration (iAMD) for progression to late AMD - A MACUSTAR study report

Hannah M P Dunbar; Charlotte Behning; Alison M Binns; Jan Henrik Terheyden; Stephen H Poor; Robert Finger; David P. Crabb; Sergio Leal; Adnan Tufail; Frank G Holz; Matthias Schmid; Ulrich F O Luhmann

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1485.

ARVO Annual Meeting Abstract June 2024

Improving the detection of progression in longitudinal microperimetry data in age-related macular degeneration by using pointwise analysis of data - a MACUSTAR study report

Jeremy TAN; Giovanni Montesano; Charlotte Behning; Hannah M P Dunbar; Robert Finger; Jan Henrik Terheyden; Stephen H Poor; Sergio Leal; Adnan Tufail; Frank G Holz; Ulrich F O Luhmann; David P. Crabb

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5686.

ARVO Annual Meeting Abstract July 2019

Overexpression of HTRA1 in mice compromises the extracellular matrix integrity in Bruch’s membrane and choroidal/retinal vasculature

Omar Delgado; erika lima; Natasha Buchanan; Hui Li; Joanna Vrouvlianis; Barrett Leehy; Chad E Bigelow; Junzheng Yang; Jean-Rene Galarneau; Emily Meseck; Christopher Hayden; Stephen H Poor; Sha-Mei Liao

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1233.

ARVO Annual Meeting Abstract July 2019

Complement factor B is necessary for sub-RPE deposit formation in Efemp1 R345W /R345W knock-in mice

Maura Crowley; Donita Garland; Rosario Fernandez-Godino; Tomas Rejtar; Natasha Buchanan; Karen Anderson; Holger Sellner; Muneto Mogi; Y. Karen Wang; Bruce Jaffee; Stephen H Poor; Thaddeus Dryja; Eric A Pierce; Sha-Mei Liao

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1241.

ARVO Annual Meeting Abstract July 2019

Erythropoietin (EPO) overexpression induces a DME-like phenotype in the mouse retina

Jorge Aranda; Nalini V Rangaswamy; Hui Li; Joanna Vrouvlianis; Maura Crowley; John T Demirs; Junzheng Yang; Adrian Will-Orrego; Terri McGee; Chad E Bigelow; Stephen H Poor

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3664.

ARVO Annual Meeting Abstract July 2019

Development of anti-drug antibodies following intravitreal administration of anti-C3b Fabs in cynomolgus monkeys and rabbits

Michael Twarog; Steve Louie; Mark Milton; Ana Carrion; Omar Delgado; Maura Crowley; Natasha Buchanan; Shawn Hanks; John T Demirs; Chad E Bigelow; Stephen H Poor; Yong-in Kim; Sha-Mei Liao

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4014.

ARVO Annual Meeting Abstract July 2019

Characterization of a mouse model of RPE pathology

Ivana Arellano; Hui Li; Jorge Aranda; Shawn Hanks; Tim Pagliaro; Joanna Vrouvlianis; Nalini V Rangaswamy; Chad E Bigelow; Stephen H Poor

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):192.

ARVO Annual Meeting Abstract July 2018

Topical VEGF receptor inhibitor, LHA510, did not demonstrate efficacy in a Proof-of-Concept study in patients with neovascular age-related macular degeneration (nv AMD)

Stephen H Poor; Christopher M Adams; Michael Ferriere; Andreas Weichselberger; Cynthia L Grosskreutz; Georges Weissgerber

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2394.

ARVO Annual Meeting Abstract July 2018

Development of an ex vivo assay to measure mitochondrial metabolism of mouse posterior eye tissue

Steve Louie; Barrett Leehy; Hui Li; Jorge Aranda; Stephen H Poor; Tony Walshe

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4009.

ARVO Annual Meeting Abstract June 2017

A topical VEGF inhibitor optimized for ocular indications

Stephen H Poor; Christopher Adams; Chad E Bigelow; Debby Long; Penny Yao; Elizabeth Fassbender; Siyuan Shen; Jim Chastain; Yubin Qiu; Bruce D Jaffee

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1975.

ARVO Annual Meeting Abstract September 2016

Ocular inflammatory cell infiltrates and angiogenesis are augmented by administration of the toll-like receptor-2 (TLR-2) ligand in a mouse model of choroidal neovascularization (CNV)

Stephen H Poor; Yubin Qiu; Adrian Will-Orrego; Elizabeth Fassbender; Siyuan Shen; Maura Crowley; Sha-Mei Liao; Bruce D Jaffee

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):484.

ARVO Annual Meeting Abstract September 2016

Systemic VEGF Inhibition does not modulate ocular inflammatory cell infiltrate in the murine laser-induced choroidal neovascularization (CNV) Model

Adrian Will-Orrego; Sha-Mei Liao; Yubin Qiu; Elizabeth Fassbender; Siyuan Shen; Namrata Kotagiri; Bruce D Jaffee; Stephen H Poor

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3323.

ARVO Annual Meeting Abstract June 2015

Weekly oral delivery of a vascular endothelial growth factor receptor (VEGFR) inhibitor compound optimized for ocular exposure improves safety and maintains efficacy compared to daily dosing

Yubin Qiu; Siyuan Shen; Elizabeth S Fassbender; Amber Woolfenden; Debby Long; Ron Newton; Erik Meredith; Bruce D Jaffee; Stephen H Poor; Ophthalmology, Novartis Institutes for BioMedical Research, Inc.

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):151.

ARVO Annual Meeting Abstract June 2015

A vascular endothelial growth factor receptor inhibitor (VEGFRi) achieves topical efficacy in rat and monkey models of choroidal neovascularization (CNV)

Stephen H Poor; Yubin Qiu; Amber Woolfenden; Debby Long; Christopher M Adams; Jason Elliott; Vinayak Hosagrahara; Jeremy M Sivak; Bruce D Jaffee

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3380.

Retina October 2014

Reliability of the Mouse Model of Choroidal Neovascularization Induced by Laser Photocoagulation

PDF

Stephen H. Poor; Yubin Qiu; Elizabeth S. Fassbender; Siyuan Shen; Amber Woolfenden; Andrea Delpero; Yong Kim; Natasha Buchanan; Thomas C. Gebuhr; Shawn M. Hanks; Erik L. Meredith; Bruce D. Jaffee; Thaddeus P. Dryja
TAGS: choroidal neovascularization, lasers, light coagulation, mice, reliability
Invest. Ophthalmol. Vis. Sci.. 2014; 55(10):6525-6534. https://doi.org/10.1167/iovs.14-15067

Includes: Supplemental Content

ARVO Annual Meeting Abstract April 2014

Intravitreal (IVT) injection exacerbates murine choroidal neovascularization (CNV) area by a MYD88 dependent mechanism

Elizabeth Fassbender; Yubin Qiu; Siyuan Shen; Amber Woolfenden; Andrea Delpero; Yong Kim; Bruce D Jaffee; Stephen H Poor

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1194.

ARVO Annual Meeting Abstract April 2014

Recombinant human vascular endothelial growth factor165(VEGF) derived from different expression systems does not affect in vitro, but does impact in vivo activity profiles

Yubin Qiu; Chad E Bigelow; Luciana Ferrara; Siyuan Shen; Michael P Maker; Elizabeth Fassbender; Yong Kim; Andrea DeErkenez; Barrett Leehy; Stephen H Poor

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):600.

ARVO Annual Meeting Abstract March 2012

In Vitro And In Vivo Response Of VEGFR-2 To VEGF165 With/Without Ranibizumab

Amber Woolfenden; Elizabeth Fassbender; Siyuan Shen; Kathyrn McAllister; Lisa Baker; Bruce D. Jaffee; Stephen H. Poor; Yubin Qiu

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2962.

ARVO Annual Meeting Abstract March 2012

Complement Play A Minor Role In Mouse Laser-induced Choroidal Neovascularization

Stephen H. Poor; Elizabeth Fassbender; Siyuan Shen; Yubin Qiu; Amber Woolfenden; John Demirs; Karen Anderson; Bruce D. Jaffee

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1642.

ARVO Annual Meeting Abstract April 2011

Analysis of Laser-induced Choroidal Neovascularization (CNV) Area from 143 Control Cohorts

Siyuan Shen; Yubin Qiu; Elizabeth Fassbender; Amber Woolfenden; Bruce D. Jaffee; Stephen H. Poor

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3974.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

The prognostic power of baseline visual function deficits in intermediate age-related macular degeneration (iAMD) for progression to late AMD - A MACUSTAR study report

Improving the detection of progression in longitudinal microperimetry data in age-related macular degeneration by using pointwise analysis of data - a MACUSTAR study report

Overexpression of HTRA1 in mice compromises the extracellular matrix integrity in Bruch’s membrane and choroidal/retinal vasculature

Complement factor B is necessary for sub-RPE deposit formation in Efemp1 R345W /R345W knock-in mice

Erythropoietin (EPO) overexpression induces a DME-like phenotype in the mouse retina

Development of anti-drug antibodies following intravitreal administration of anti-C3b Fabs in cynomolgus monkeys and rabbits

Characterization of a mouse model of RPE pathology

Topical VEGF receptor inhibitor, LHA510, did not demonstrate efficacy in a Proof-of-Concept study in patients with neovascular age-related macular degeneration (nv AMD)

Development of an ex vivo assay to measure mitochondrial metabolism of mouse posterior eye tissue

A topical VEGF inhibitor optimized for ocular indications

Ocular inflammatory cell infiltrates and angiogenesis are augmented by administration of the toll-like receptor-2 (TLR-2) ligand in a mouse model of choroidal neovascularization (CNV)

Systemic VEGF Inhibition does not modulate ocular inflammatory cell infiltrate in the murine laser-induced choroidal neovascularization (CNV) Model

Weekly oral delivery of a vascular endothelial growth factor receptor (VEGFR) inhibitor compound optimized for ocular exposure improves safety and maintains efficacy compared to daily dosing

A vascular endothelial growth factor receptor inhibitor (VEGFRi) achieves topical efficacy in rat and monkey models of choroidal neovascularization (CNV)

Reliability of the Mouse Model of Choroidal Neovascularization Induced by Laser Photocoagulation

Intravitreal (IVT) injection exacerbates murine choroidal neovascularization (CNV) area by a MYD88 dependent mechanism

Recombinant human vascular endothelial growth factor165(VEGF) derived from different expression systems does not affect in vitro, but does impact in vivo activity profiles

In Vitro And In Vivo Response Of VEGFR-2 To VEGF165 With/Without Ranibizumab

Complement Play A Minor Role In Mouse Laser-induced Choroidal Neovascularization

Analysis of Laser-induced Choroidal Neovascularization (CNV) Area from 143 Control Cohorts

To View More...

You must be signed into an individual account to use this feature.